USANA Health Sciences
American multi-level marketing company
USNA NYSE
SEC CIK 896264 LEI 549300YTURXE814MAH96
Follow USANA Health Sciences
Weekly email: filings, results
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $925.3M | $10.8M |
| FY25 | $854.5M | $42M |
| FY24 | $921M | $63.8M |
| FY23 | $998.6M | $69.4M |
| FY22 | $1.2B | $116.5M |
| FY21 | $1.1B | $124.7M |
| FY20 | $1.1B | $100.5M |
| FY19 | $1.2B | $126.2M |
| FY18 | $1B | $62.5M |
| FY17 | $1B | $100M |
| FY16 | $918.5M | $94.7M |
| FY15 | $790.5M | $76.6M |
| FY14 | $718.2M | $79M |
| FY13 | $648.7M | $66.4M |
| FY12 | $581.9M | $50.8M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 78.3% | 4% | 1.2% |
| FY25 | 81.1% | 7.8% | 4.9% |
| FY24 | 80.8% | 10.1% | 6.9% |
| FY23 | 80.6% | 10.8% | 6.9% |
| FY22 | 81.6% | 14.3% | 9.8% |
| FY21 | 81.6% | 15.6% | 11% |
| FY20 | 82.3% | 13.8% | 9.5% |
| FY19 | 83.1% | 15.8% | 10.6% |
| FY18 | 82.9% | 12.7% | 6% |
| FY17 | 82.1% | 13.8% | 9.9% |
| FY16 | 82.6% | 15.4% | 10.3% |
| FY15 | 82.2% | 14.7% | 9.7% |
| FY14 | 82.3% | 16.3% | 11% |
| FY13 | 82.1% | 15.1% | 10.2% |
| FY12 | 82.5% | 13.3% | 8.7% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | $8.5M |
| FY25 | $50.9M |
| FY24 | $56.1M |
| FY23 | $93.5M |
| FY22 | $108.5M |
| FY21 | $145.3M |
| FY20 | $110.2M |
| FY19 | $140.7M |
| FY18 | $110.6M |
| FY17 | $104.2M |
| FY16 | $87.7M |
| FY15 | $84.8M |
| FY14 | $90.8M |
| FY13 | $84.4M |
| FY12 | $59.5M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY26 | $27.5M |
| FY25 | $9.4M |
| FY24 | $11.6M |
| FY23 | $25.4M |
| FY22 | $177.8M |
| FY21 | $57M |
| FY20 | $150M |
| FY19 | $105.4M |
| FY18 | $50M |
| FY17 | $64.6M |
| FY16 | $61.2M |
| FY15 | $138.8M |
| FY14 | $18.1M |
| FY13 | $68.3M |
| FY12 | $33.5M |
- USANA Health Sciences
- Healthcare median
Show the numbers
| Year | USANA Health Sciences | Healthcare median |
|---|---|---|
| FY26 | 1.2% | −11.1% |
| FY25 | 4.9% | −30.6% |
| FY24 | 6.9% | −47% |
| FY23 | 6.9% | −58% |
| FY22 | 9.8% | −80.4% |
| FY21 | 11% | −71.8% |
| FY20 | 9.5% | −62.2% |
| FY19 | 10.6% | −46.2% |
| FY18 | 6% | −49.6% |
| FY17 | 9.9% | −45.9% |
| FY16 | 10.3% | −36% |
| FY15 | 9.7% | −37.8% |
| FY14 | 11% | −35.5% |
| FY13 | 10.2% | −37.1% |
| FY12 | 8.7% | −29.1% |